Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models

A novel pathway of vitamin D(3) (D(3)) metabolism, initiated by C20-hydroxylation of D(3) by CYP11A1, has been confirmed to operate in vivo. Its major product, 20(OH)D(3), exhibits antiproliferative activity in vitro comparable to that of 1,25(OH)(2)D(3), but is noncalcemic in mice and rats. To furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Skobowiat, Cezary, Oak, Allen S.W., Kim, Tae-Kang, Yang, Chuan He, Pfeffer, Lawrence M., Tuckey, Robert C., Slominski, Andrzej T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354773/
https://www.ncbi.nlm.nih.gov/pubmed/28039464
http://dx.doi.org/10.18632/oncotarget.14193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354773/
https://www.ncbi.nlm.nih.gov/pubmed/28039464
http://dx.doi.org/10.18632/oncotarget.14193

Ejemplares similares